Effective April 15, patients may bring one visitor to an appointment.
Learn more about this and other COVID-19 related updates

Clinical Trials & Research

Ph 2 Nivo+Ipil, Ipil mono or Caba CR mPC

A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer (CA209-650)

Disease Types: Prostate,&nbs

Available at: {clinical_trial_location backspace="7"}Ph 2 Nivo+Ipil, Ipil mono or Caba CR mPC, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}